(1)
Samira, C. P.; Andrisa, R. S. Efficacy and Safety of Imiquimod 5% As Primary Therapy in Management of Nodular Basal Cell Carcinoma of the Eyelid. OI 2017, 42 (2). https://doi.org/10.35749/journal.v42i2.80.